Skip to main navigation Skip to search Skip to main content

Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)110-111
Number of pages2
JournalLung Cancer
Volume129
DOIs
Publication statusPublished - Mar 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this